Vivek Dhar Dwivedi
Saveetha Institute of Medical and Technical Sciences, Bioinformatics Research Division, Quanta Calculus, Pathfinder Research and Training Foundation
About
Dr. Vivek Dhar Dwivedi is a Principal Scientist and Group Leader at the Bioinformatics Research Division, Quanta Calculus, Greater Noida, India. He is also currently serving as an Adjunct Professor in the Department of Physiology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
Dr. Dwivedi is an active researcher specializing in bioinformatics, computational biology, viral informatics, and computer-aided drug discovery. His research focuses on developing advanced bioinformatics tools and computational approaches for infectious disease research, therapeutic target identification, and rational drug discovery.
He serves as an active member of the Scientific Advisory Board of the World Society for Virology and is associated with the editorial and peer-review activities of several international scientific journals, including Scientific Reports, BMC Infectious Diseases, Advances in Virology, Discover Viruses, and Current Indian Science.
Prior to his current appointments, Dr. Dwivedi worked at the Centre for Bioinformatics, Computational and Systems Biology, Pathfinder Research and Training Foundation, Greater Noida; ICMR–National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra; Forest Research Institute (FRI), Dehradun; and Uttaranchal College of Science & Technology, Dehradun, India.
His contributions to research have been recognized through several prestigious honors, including the Best Researcher Award (2021) for outstanding contributions to innovative research, the Young Scientist Award at the 9th Academic Brilliance Awards (2021) by Education Expo TV, and the Highest Publication Award (2014) from the Department of Biotechnology & Bioinformatics, Uttaranchal College of Science & Technology.
Dr. Dwivedi has authored more than 100 peer-reviewed research and review articles published by leading international publishers, including Springer Nature, Elsevier, Taylor & Francis, and Oxford University Press. He has also contributed 33 single-gene and 2 whole bacterial genome submissions to the GenBank database maintained by the National Center for Biotechnology Information (NCBI), reflecting his significant contributions to genomic and bioinformatics research.
Employment
-
Saveetha Institute of Medical and Technical Sciences Adjunct Professor2023 - Present
-
Bioinformatics Research Division, Quanta Calculus Principal Scientist/Group Leader2022 - Present
-
Pathfinder Research and Training Foundation Scientist/Group Leader2018 - 2022
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (88)
- Disrupting Marburg virus replication: Structural and energetic insights into VP35 inhibition Save
- Molecular Dynamics and Energetic Insights into Novel PARP15 Inhibitors: A Structural Approach for Targeting BRCA-Mutated Breast Cancer Save
- Machine Learning‐Based Discovery of Natural PknB Inhibitors Against Drug‐Resistant Mycobacterium tuberculosis With Multi‐Scale Modeling and Quantum Mechanical Validation Save
- Investigating Pb2 CAP-binding domain inhibitors from marine bacteria for targeting the influenza A H5N1 Save
- Multi-omics integration reveals CYP2B6 as a central node in the molecular landscape of non-small cell lung cancer Save
- Machine learning-guided in Silico identification of Na+-NQR inhibitors from Berberis vulgaris and Hydrastis Canadensis phytochemicals against Vibrio cholerae Save
- Repurposing Metal‐Based Therapeutics for Human Metapneumovirus (HMPV): An Integrative Computational Approach Save
- Harnessing Natural Product Compounds to Target Dormancy Survival Regulator (DosR) in Latent Tuberculosis Infection (LTBI): An In Silico Strategy Against Dormancy Save
- Exploring plant-derived small molecules as inhibitors of Marburg virus RNA binding protein activity Save
- Machine learning-aided identification of natural compounds targeting Marburg virus VP40 with potential antiviral activity Save